Nurix Therapeutics (NRIX) EBT Margin Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -89,617.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -89,617.00 |
| Feb 28, 2026 | -110,136.00 |
| Nov 30, 2025 | -13,544.00 |
| Aug 31, 2025 | -70,651.00 |
| May 31, 2025 | 27,072.00 |
| Feb 28, 2025 | -5,558.00 |
| Nov 30, 2024 | -16,392.00 |
| Aug 31, 2024 | -18,800.00 |
| May 31, 2024 | -28,851.00 |
| Feb 29, 2024 | 7,132.00 |
| Nov 30, 2023 | 41,196.00 |
| Aug 31, 2023 | 22,332.00 |
| May 31, 2023 | 31,800.00 |
| Feb 28, 2023 | 12,097.00 |
| Nov 30, 2022 | -17,957.00 |
| Aug 31, 2022 | -14,112.00 |
| May 31, 2022 | -2,705.00 |
| Feb 28, 2022 | 4,093.00 |
| Nov 30, 2021 | -21,207.00 |
| Aug 31, 2021 | 17,083.00 |